Publications by authors named "Aude Frevol"

Claim this Profile
S
Safety and immunogenicity of a thermostable ID93 + GLA-SE tuberculosis vaccine candidate in healthy adults.
Zachary K Sagawa, Cristina Goman, Aude Frevol, Azra Blazevic, Janice Tennant

Nat Commun· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial.
Tracey A Day, Adam Penn-Nicholson, Angelique Kany Kany Luabeya, Andrew Fiore-Gartland, Nelita Du Plessis, Aude Frevol

Lancet Respir Med· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA-SE) in healthy adults.
Malcolm S Duthie, Aude Frevol, Tracey Day, Rhea N Coler, Julie Vergara

Vaccine· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The adjuvant GLA-AF enhances human intradermal vaccine responses.
Darrick Carter, Neal van Hoeven, Susan Baldwin, Yotam Levin, Efrat Kochba, Aude Frevol

Sci Adv· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis